Pneumatic Nebulizers Market Growth is Propelled by Revolutionary Technological Progress

San Francisco, Calif., USA, Nov 18, 2022 — /EPR Network/ —

Pneumatic Nebulizers Industry Overview

The global pneumatic nebulizers market size is anticipated to reach USD 1.02 billion by 2028, registering a CAGR of 6.0% over the forecast period, according to a new report by Grand View Research, Inc. The market has shown constant growth in the adoption of pneumatic nebulizers as home healthcare devices have been gaining popularity in recent years. Miniaturization of products and technological advancements are also boosting the adoption of home healthcare devices.

North America pneumatic nebulizers market size, by product, 2018 - 2028 (USD Million)

As per the Minnesota Department of Health, administration of medication through nebulizer represents a lower infection risk as compared to other aerosol-producing procedures. On the other hand, according to ISAM, aerosols from the nebulizer do not carry viral particles derived from the patient as they are generated from the fluid in the nebulized chamber, which is a non-patient source. Aerosols generated by nebulizers comprise pathogens only when the healthcare workers or patients contaminate the nebulizers. Various recommendations from institutes do not clarify whether it is appropriate to use nebulizers during the pandemic.

Pneumatic Nebulizers Market Segmentation

Grand View Research has segmented the global pneumatic nebulizers market on the basis of the product, end-use, and region:

Based on the Product Insights, the market is segmented into Breath-actuated and Vented

  • The breath-actuated product segment held the largest revenue share of over 64% in 2020.
  • The breath-actuated nebulizers elucidate higher drug delivery capacity and lesser dosage wastage features. Thus, the segment, delivering advanced inhalation therapy, is expected to dominate the market over the forecast period.

Based on the Product Insights, the market is segmented into Hospitals & Clinics and Home Healthcare

  • The hospitals & clinics segment dominated the market in 2020, accounting for a revenue share of more than 66%.
  • Over the recent years, home healthcare devices have been gaining popularity, thereby driving the segment growth.
  • The easy availability of compact nebulizers ideal for home use and technological innovations to improve functionality are also increasing their adoption in-home healthcare.

Pneumatic Nebulizers Regional Outlook

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Key Companies Profile & Market Share Insights

The global market is fairly competitive. The most notable participants in the market are Koninklijke Philips N.V. and Omron Corp. Key players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge over each other. For instance, in January 2020, OMRON Corp. announced the opening of the Automation Center Tokyo (ATC-TOKYO) in Tokyo. With this center, customers can join the company to find solutions for any challenges arising during production.

Some prominent players in the global Pneumatic Nebulizers market include:

  • Koninklijke Philips N.V.
  • Omron Corp.
  • PARI Pharma
  • General Electric Company
  • Allied Healthcare Products, Inc.
  • BD (Becton, Dickinson & Company)
  • GF Health Products, Inc.
  • Medline Industries, Inc.
  • Briggs Healthcare
  • Vectura Group Plc

Order a free sample PDF of the Pneumatic Nebulizers Market Intelligence Study, published by Grand View Research.

Matched content

Editor’s pick

Express Press Release Distribution